Page 2 - Mcelu News Today

Celularity Inc. (NASDAQ:CELU – Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 1,400,000 shares, a decline of 17.2% from the July 15th total of 1,690,000 shares. Based on an average trading volume of 759,000 shares, the short-interest ratio is […]

Celularity Inc. (NASDAQ:CELU – Get Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 1,560,000 shares, a decrease of 59.1% from the June 15th total of 3,810,000 shares. Based on an average daily trading volume, of 629,600 shares, […]

Celularity Inc. (NASDAQ:CELU – Get Rating) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,390,000 shares, an increase of 10.8% from the May 15th total of 3,060,000 shares. Based on an average trading volume of 463,700 shares, the days-to-cover ratio is currently […]

Celularity Inc. (NASDAQ:CELU – Get Rating) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 3,790,000 shares, a drop of 26.7% from the March 31st total of 5,170,000 shares. Approximately 5.4% of the company’s shares are sold short. Based on an average daily […]

Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, an increase of 8.8% from the March 15th total of 4,750,000 shares. Based on an average daily volume of 570,100 shares, the days-to-cover […]

Celularity Inc. (NASDAQ:CELU – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,170,000 shares, a growth of 8.8% from the March 15th total of 4,750,000 shares. Approximately 7.4% of the company’s shares are short sold. Based on […]

Celularity Inc. (NASDAQ:CELU – Get Rating) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,750,000 shares, a growth of 38.1% from the February 28th total of 3,440,000 shares. Currently, 9.2% of the company’s shares are sold short. Based on […]

Celularity (NASDAQ:CELU – Get Rating) and Kezar Life Sciences (NASDAQ:KZR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Celularity and Kezar […]

Equities research analysts expect Celularity Inc. (NASDAQ:CELU – Get Rating) to post earnings of ($0.23) per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Celularity’s earnings, with the highest EPS estimate coming in at ($0.11) and the lowest estimate coming in at ($0.29). The company is scheduled to […]

Zacks Investment Research lowered shares of Celularity (NASDAQ:CELU – Get Rating) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified […]